The Pharma Data

APRIL 14, 2021

Nasdaq: BIIB) today reported topline results from the Phase 2 KINETIC Study evaluating SAGE-324 in the treatment of people with essential tremor (ET). The collaboration partners are pleased with the progress to date and are planning next steps for development of SAGE-324. “In Sage Therapeutics to host conference call today at 8 a.m.

Medicine 52

Medicine Development FDA Approval Trials 52

XTalks

MARCH 31, 2023

The current investigation builds on a project from 2020 when BMS set out on SpaceX’s CRS-21 to look at ways to improve crystallizing monoclonal antibodies to gain better insights into their structure and crystallization kinetics in microgravity with the overarching goal of improving drug formulation and delivery.

Protein 97

Protein Research Development Manufacturing 97

Pharmaceutical Technology

JUNE 26, 2022

As every molecule and development program is unique, there is no single drug substance synthesis and manufacturing solution, so understanding what processes and technologies are available, what strategy is best, and who to partner with is key. .

Manufacturing 130

Manufacturing Drugs Production Development 130